MUSTANG BIO, INC. — Director's Dealing 2017

Jun 30, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MUSTANG BIO, INC. (NONE)
CIK: 0001680048
Period of Report: 2017-04-24

Reporting Person: Litchman Manuel MD (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (Restricted)	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$5.73	2027-04-24	Common Stock (1041675)		Direct

Footnotes

F1: The options will vest according to the following schedule: One half of the shares subject to the Option will vest over time (the "Time Based Option"), with twenty five percent (25%) of the Time Based Option vesting after twelve (12) months of employment, and the remaining shares vesting in twelve (12) equal quarterly installments thereafter, subject to Dr. Litchman's continuous service to the Company on each vesting date.